✦ LIBER ✦

CYP2D6 Genotyping and Tamoxifen: An Unfinished Story in the Quest for Personalized Medicine

✍ Scribed by Jonas A. de Souza; Olufunmilayo I. Olopade

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Personalized medicine in breast cancer:

✍ Ruddy, Kathryn J.; Desantis, Stephen D.; Gelman, Rebecca S.; Wu, Alan H. B.; Pun 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 237 KB

Genotypes for the cytochrome P450 enzyme

✍ L. Bathum; K. Andersen-Ranberg; J. Boldsen; K. Brøsen; B. Jeune 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 138 KB

Efficacy of tamoxifen based on cytochrom

✍ Serrano, D; Lazzeroni, M; Zambon, C-F; Macis, D; Maisonneuve, P; Johansson, H; G 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 287 KB

CYP2D6 genotypes, endoxifen levels, and

✍ Richard R Love, Zuerenesay Desta, David Flockhart, Todd Skaar… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 167 KB

The use of the13C-dextromethorphan breat

✍ F. L. Opdam, V. O. Dezentje, J. den Hartigh… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 353 KB

CYP2D6 Genotype and Tamoxifen Response i

✍ Regan, M. M.; Leyland-Jones, B.; Bouzyk, M.; Pagani, O.; Tang, W.; Kammler, R.; 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 529 KB